165 related articles for article (PubMed ID: 36966556)
1. Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations.
Khan A; Adil S; Qudsia HA; Waheed Y; Alshabrmi FM; Wei DQ
Comput Biol Med; 2023 May; 158():106797. PubMed ID: 36966556
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
3. Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.
Rabaan AA; Alwashmi ASS; Mashraqi MM; Alshehri AA; Alawfi A; Alshengeti A; Najim MA; AlShehail BM; AlShahrani AJ; Garout M
Mol Divers; 2023 Aug; ():. PubMed ID: 37531040
[TBL] [Abstract][Full Text] [Related]
4. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
[TBL] [Abstract][Full Text] [Related]
5. Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations.
Suleman M; Ahmad T; Shah K; Albekairi NA; Alshammari A; Khan A; Wei DQ; Yassine HM; Crovella S
Front Pharmacol; 2023; 14():1328308. PubMed ID: 38269277
[TBL] [Abstract][Full Text] [Related]
6. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
7. Identification of probable inhibitors for the DNA polymerase of the Monkeypox virus through the virtual screening approach.
Kumari S; Chakraborty S; Ahmad M; Kumar V; Tailor PB; Biswal BK
Int J Biol Macromol; 2023 Feb; 229():515-528. PubMed ID: 36584781
[TBL] [Abstract][Full Text] [Related]
8. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study.
Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872
[TBL] [Abstract][Full Text] [Related]
9. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
Tan C; Zhu F; Pan P; Wu A; Li C
Front Immunol; 2023; 14():1112816. PubMed ID: 36993967
[TBL] [Abstract][Full Text] [Related]
10. G-quadruplexes in the monkeypox virus are potential antiviral targets.
Lv L; Zhang L
J Med Virol; 2023 Jan; 95(1):e28299. PubMed ID: 36366981
[TBL] [Abstract][Full Text] [Related]
11. Identification of the myxobacterial secondary metabolites Aurachin A and Soraphinol A as promising inhibitors of thymidylate kinase of the Monkeypox virus.
Ali Y; Khan AA; Alanazi AM; Abdikakharovich SA; Shah JA; Ren ZG; Khattak S
Mol Divers; 2024 Jan; ():. PubMed ID: 38183513
[TBL] [Abstract][Full Text] [Related]
12. Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: An immunoinformatics approach.
Bhattacharya M; Chatterjee S; Nag S; Dhama K; Chakraborty C
Travel Med Infect Dis; 2022; 50():102481. PubMed ID: 36265732
[TBL] [Abstract][Full Text] [Related]
13. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
14. Identification of Antiviral Compounds against Monkeypox Virus Profilin-like Protein A42R from
Bajrai LH; Alharbi AS; El-Day MM; Bafaraj AG; Dwivedi VD; Azhar EI
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431817
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of mRNA cap (guanine-N7) methyltransferase E12 subunit from monkeypox virus and discovery of its inhibitors.
Wang DP; Zhao R; Wang HF; Wang MY; Hu WS; Lin MM; Shu W; Sun YJ; Cao JM; Cui W; Zhou X
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127565. PubMed ID: 37866584
[TBL] [Abstract][Full Text] [Related]
16. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
[TBL] [Abstract][Full Text] [Related]
17. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
18. Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus.
Kindrachuk J; Arsenault R; Kusalik A; Kindrachuk KN; Trost B; Napper S; Jahrling PB; Blaney JE
Mol Cell Proteomics; 2012 Jun; 11(6):M111.015701. PubMed ID: 22205724
[TBL] [Abstract][Full Text] [Related]
19. Molecular level investigation for identifying potential inhibitors against thymidylate kinase of monkeypox through
Koirala S; Samanta S; Mahapatra S; Ursal KD; Poddar S; Kar P
J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37909473
[TBL] [Abstract][Full Text] [Related]
20. Multi-epitope chimeric vaccine design against emerging Monkeypox virus
Aiman S; Alhamhoom Y; Ali F; Rahman N; Rastrelli L; Khan A; Farooq QUA; Ahmed A; Khan A; Li C
Front Immunol; 2022; 13():985450. PubMed ID: 36091024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
